Work

Evaluating the Evidence for CYP2C19 Inhibitor Classifications: A Scoping Review

Year: 2025

Type: article

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1002/cpt.3712

Authors: Jean G. Malavé, Andrés Lopez, Thi Doan, Emily J. Cicali, Zeruesenay Desta, Caitrin W. McDonough, Larisa H. Cavallari

Institutions: University of Florida Health, University of Florida, Indiana University Indianapolis, Indiana University School of Medicine

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410519062

FWCI: 3.435

Cites: 41

Cited by: 4

Related to: 10